Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells

Rhodamine 123 is a fluorescent dye that localizes in mitochondria, is a substrate for the multidrug resistance pump, and is retained for long periods of time by carcinoma cells. 17 beta-Estradiol causes GH4C1 cells (rat pituitary tumor cells) to lose rhodamine 123 fluorescence faster than untreated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular pharmacology 1993-01, Vol.43 (1), p.51-56
Hauptverfasser: JANCIS, E. M, CARBONE, R, LOECHNER, K. J, DANNIES, P. S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 56
container_issue 1
container_start_page 51
container_title Molecular pharmacology
container_volume 43
creator JANCIS, E. M
CARBONE, R
LOECHNER, K. J
DANNIES, P. S
description Rhodamine 123 is a fluorescent dye that localizes in mitochondria, is a substrate for the multidrug resistance pump, and is retained for long periods of time by carcinoma cells. 17 beta-Estradiol causes GH4C1 cells (rat pituitary tumor cells) to lose rhodamine 123 fluorescence faster than untreated cells. We found that estradiol induces accumulation of the mRNA for the multidrug resistance pump 3-5-fold, with maximum induction occurring within 1 day at 10(-9) M estradiol. Immunoblot analysis demonstrated that estradiol induces a protein of 150 kDa that reacts with an antibody to P-glycoprotein, the multidrug resistance pump. The reduced retention of rhodamine 123 caused by estradiol is prevented by verapamil and cyclosporin, inhibitors of the pump. A clone resistant to the effects of estradiol on rhodamine 123 has greatly reduced levels of mRNA for the pump. The effect of estradiol is more marked on rhodamine 123 retention than it is on that of rhodamine 110 or tetramethylrhodamine methyl ester. We conclude that estradiol enhances rhodamine 123 efflux by inducing the multidrug resistance gene. The specificity for rhodamine 123, compared with other analogs, may be caused by differences in accessibility to the pump.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_75570860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16531723</sourcerecordid><originalsourceid>FETCH-LOGICAL-h295t-ee6718cdc8fb6d6ad90daef1298c88ffc904d41a94fab323122b77d739feff273</originalsourceid><addsrcrecordid>eNqFkEtLxDAAhIso67r6E4QcxFshj6ZJjrKsDxC8KHgraR7bLG1T80D991YsevQ0h_kYZuaoWCOKUQkRQsfFGkJcl1zQ19PiLMYDhKiiHK6KFa8wYbVYF4ddTEFq53vgRp1Vcn4E3oLQeS0HNxqAMAHG2j5_ADlqkDoDhtwnp0Peg2Cii0mOyoApD9OcAYJMYHIpuyTDJ0h58AEo0_fxvDixso_mYtFN8XK7e97el49Pdw_bm8eyw4Km0piaIa604ratdS21gFoai7DginNrlYCVrpAUlZUtwQRh3DKmGRF2rokZ2RTXP7lT8G_ZxNQMLn43kKPxOTaMUgZ5Df8FUU0JYpjM4OUC5nYwupmCG-ZxzfLi7F8tvoxK9jbMh7j4i1W0FlXF_7DO7bt3F0wzdTIMUvne72eMNKihiHwBoYuKgg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16531723</pqid></control><display><type>article</type><title>Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>JANCIS, E. M ; CARBONE, R ; LOECHNER, K. J ; DANNIES, P. S</creator><creatorcontrib>JANCIS, E. M ; CARBONE, R ; LOECHNER, K. J ; DANNIES, P. S</creatorcontrib><description>Rhodamine 123 is a fluorescent dye that localizes in mitochondria, is a substrate for the multidrug resistance pump, and is retained for long periods of time by carcinoma cells. 17 beta-Estradiol causes GH4C1 cells (rat pituitary tumor cells) to lose rhodamine 123 fluorescence faster than untreated cells. We found that estradiol induces accumulation of the mRNA for the multidrug resistance pump 3-5-fold, with maximum induction occurring within 1 day at 10(-9) M estradiol. Immunoblot analysis demonstrated that estradiol induces a protein of 150 kDa that reacts with an antibody to P-glycoprotein, the multidrug resistance pump. The reduced retention of rhodamine 123 caused by estradiol is prevented by verapamil and cyclosporin, inhibitors of the pump. A clone resistant to the effects of estradiol on rhodamine 123 has greatly reduced levels of mRNA for the pump. The effect of estradiol is more marked on rhodamine 123 retention than it is on that of rhodamine 110 or tetramethylrhodamine methyl ester. We conclude that estradiol enhances rhodamine 123 efflux by inducing the multidrug resistance gene. The specificity for rhodamine 123, compared with other analogs, may be caused by differences in accessibility to the pump.</description><identifier>ISSN: 0026-895X</identifier><identifier>EISSN: 1521-0111</identifier><identifier>PMID: 8423769</identifier><identifier>CODEN: MOPMA3</identifier><language>eng</language><publisher>Bethesda, MD: American Society for Pharmacology and Experimental Therapeutics</publisher><subject>Animals ; Antineoplastic agents ; Biological and medical sciences ; Cyclosporins - pharmacology ; Drug Resistance - genetics ; Estradiol - pharmacology ; General aspects ; Medical sciences ; Pharmacology. Drug treatments ; Pituitary Neoplasms - metabolism ; Rats ; Rhodamine 123 ; Rhodamines - pharmacokinetics ; RNA, Messenger - analysis ; Tumor Cells, Cultured ; Verapamil - pharmacology</subject><ispartof>Molecular pharmacology, 1993-01, Vol.43 (1), p.51-56</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4022</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4569448$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8423769$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JANCIS, E. M</creatorcontrib><creatorcontrib>CARBONE, R</creatorcontrib><creatorcontrib>LOECHNER, K. J</creatorcontrib><creatorcontrib>DANNIES, P. S</creatorcontrib><title>Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>Rhodamine 123 is a fluorescent dye that localizes in mitochondria, is a substrate for the multidrug resistance pump, and is retained for long periods of time by carcinoma cells. 17 beta-Estradiol causes GH4C1 cells (rat pituitary tumor cells) to lose rhodamine 123 fluorescence faster than untreated cells. We found that estradiol induces accumulation of the mRNA for the multidrug resistance pump 3-5-fold, with maximum induction occurring within 1 day at 10(-9) M estradiol. Immunoblot analysis demonstrated that estradiol induces a protein of 150 kDa that reacts with an antibody to P-glycoprotein, the multidrug resistance pump. The reduced retention of rhodamine 123 caused by estradiol is prevented by verapamil and cyclosporin, inhibitors of the pump. A clone resistant to the effects of estradiol on rhodamine 123 has greatly reduced levels of mRNA for the pump. The effect of estradiol is more marked on rhodamine 123 retention than it is on that of rhodamine 110 or tetramethylrhodamine methyl ester. We conclude that estradiol enhances rhodamine 123 efflux by inducing the multidrug resistance gene. The specificity for rhodamine 123, compared with other analogs, may be caused by differences in accessibility to the pump.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Cyclosporins - pharmacology</subject><subject>Drug Resistance - genetics</subject><subject>Estradiol - pharmacology</subject><subject>General aspects</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Pituitary Neoplasms - metabolism</subject><subject>Rats</subject><subject>Rhodamine 123</subject><subject>Rhodamines - pharmacokinetics</subject><subject>RNA, Messenger - analysis</subject><subject>Tumor Cells, Cultured</subject><subject>Verapamil - pharmacology</subject><issn>0026-895X</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtLxDAAhIso67r6E4QcxFshj6ZJjrKsDxC8KHgraR7bLG1T80D991YsevQ0h_kYZuaoWCOKUQkRQsfFGkJcl1zQ19PiLMYDhKiiHK6KFa8wYbVYF4ddTEFq53vgRp1Vcn4E3oLQeS0HNxqAMAHG2j5_ADlqkDoDhtwnp0Peg2Cii0mOyoApD9OcAYJMYHIpuyTDJ0h58AEo0_fxvDixso_mYtFN8XK7e97el49Pdw_bm8eyw4Km0piaIa604ratdS21gFoai7DginNrlYCVrpAUlZUtwQRh3DKmGRF2rokZ2RTXP7lT8G_ZxNQMLn43kKPxOTaMUgZ5Df8FUU0JYpjM4OUC5nYwupmCG-ZxzfLi7F8tvoxK9jbMh7j4i1W0FlXF_7DO7bt3F0wzdTIMUvne72eMNKihiHwBoYuKgg</recordid><startdate>19930101</startdate><enddate>19930101</enddate><creator>JANCIS, E. M</creator><creator>CARBONE, R</creator><creator>LOECHNER, K. J</creator><creator>DANNIES, P. S</creator><general>American Society for Pharmacology and Experimental Therapeutics</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19930101</creationdate><title>Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells</title><author>JANCIS, E. M ; CARBONE, R ; LOECHNER, K. J ; DANNIES, P. S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h295t-ee6718cdc8fb6d6ad90daef1298c88ffc904d41a94fab323122b77d739feff273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Cyclosporins - pharmacology</topic><topic>Drug Resistance - genetics</topic><topic>Estradiol - pharmacology</topic><topic>General aspects</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Pituitary Neoplasms - metabolism</topic><topic>Rats</topic><topic>Rhodamine 123</topic><topic>Rhodamines - pharmacokinetics</topic><topic>RNA, Messenger - analysis</topic><topic>Tumor Cells, Cultured</topic><topic>Verapamil - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JANCIS, E. M</creatorcontrib><creatorcontrib>CARBONE, R</creatorcontrib><creatorcontrib>LOECHNER, K. J</creatorcontrib><creatorcontrib>DANNIES, P. S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JANCIS, E. M</au><au>CARBONE, R</au><au>LOECHNER, K. J</au><au>DANNIES, P. S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>1993-01-01</date><risdate>1993</risdate><volume>43</volume><issue>1</issue><spage>51</spage><epage>56</epage><pages>51-56</pages><issn>0026-895X</issn><eissn>1521-0111</eissn><coden>MOPMA3</coden><abstract>Rhodamine 123 is a fluorescent dye that localizes in mitochondria, is a substrate for the multidrug resistance pump, and is retained for long periods of time by carcinoma cells. 17 beta-Estradiol causes GH4C1 cells (rat pituitary tumor cells) to lose rhodamine 123 fluorescence faster than untreated cells. We found that estradiol induces accumulation of the mRNA for the multidrug resistance pump 3-5-fold, with maximum induction occurring within 1 day at 10(-9) M estradiol. Immunoblot analysis demonstrated that estradiol induces a protein of 150 kDa that reacts with an antibody to P-glycoprotein, the multidrug resistance pump. The reduced retention of rhodamine 123 caused by estradiol is prevented by verapamil and cyclosporin, inhibitors of the pump. A clone resistant to the effects of estradiol on rhodamine 123 has greatly reduced levels of mRNA for the pump. The effect of estradiol is more marked on rhodamine 123 retention than it is on that of rhodamine 110 or tetramethylrhodamine methyl ester. We conclude that estradiol enhances rhodamine 123 efflux by inducing the multidrug resistance gene. The specificity for rhodamine 123, compared with other analogs, may be caused by differences in accessibility to the pump.</abstract><cop>Bethesda, MD</cop><pub>American Society for Pharmacology and Experimental Therapeutics</pub><pmid>8423769</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 1993-01, Vol.43 (1), p.51-56
issn 0026-895X
1521-0111
language eng
recordid cdi_proquest_miscellaneous_75570860
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Animals
Antineoplastic agents
Biological and medical sciences
Cyclosporins - pharmacology
Drug Resistance - genetics
Estradiol - pharmacology
General aspects
Medical sciences
Pharmacology. Drug treatments
Pituitary Neoplasms - metabolism
Rats
Rhodamine 123
Rhodamines - pharmacokinetics
RNA, Messenger - analysis
Tumor Cells, Cultured
Verapamil - pharmacology
title Estradiol induction of rhodamine 123 efflux and the multidrug resistance pump in rat pituitary tumor cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T06%3A54%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Estradiol%20induction%20of%20rhodamine%20123%20efflux%20and%20the%20multidrug%20resistance%20pump%20in%20rat%20pituitary%20tumor%20cells&rft.jtitle=Molecular%20pharmacology&rft.au=JANCIS,%20E.%20M&rft.date=1993-01-01&rft.volume=43&rft.issue=1&rft.spage=51&rft.epage=56&rft.pages=51-56&rft.issn=0026-895X&rft.eissn=1521-0111&rft.coden=MOPMA3&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E16531723%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16531723&rft_id=info:pmid/8423769&rfr_iscdi=true